Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INMB | AZN | AMGN | GILD | BMY |
| Company | Inmune Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.2700 | 188.14 | 348.01 | 140.43 | 58.26 |
| High | 1.2913 | 188.40 | 351.24 | 141.00 | 58.55 |
| Low | 1.1600 | 182.62 | 344.95 | 136.49 | 56.91 |
| Latest | 1.1700 | 183.60 | 347.80 | 137.21 | 57.48 |
| Change | -0.0500 | -5.33 | -2.12 | -3.90 | -0.63 |
| % Change | -4.10% | -2.82% | -0.61% | -2.76% | -1.08% |
| Volume | 2,504,200 | 2,068,000 | 9,169,000 | 15,521,800 | 65,847,700 |
| 20-Day Average Volume | 613,630 | 1,861,205 | 2,812,445 | 6,858,865 | 15,186,930 |
| Previous Close | 1.2200 | 188.93 | 349.92 | 141.11 | 58.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3088 | 196.92 | 371.69 | 145.65 | 60.38 |
| 20-Day Raw Stochastic | 2.99% | 3.59% | 6.15% | 4.51% | 9.54% |
| 20-Day Relative Strength | 39.19 | 38.49 | 41.72 | 42.26 | 44.29 |
| Weighted Alpha | -75.39 | +23.18 | +14.42 | +29.15 | +4.73 |
| Today's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.69% since 03/13/26 | -3.32% since 03/13/26 | -5.03% since 03/13/26 | -5.37% since 03/13/26 | -2.71% since 03/13/26 |
| Low | 1.1600 on 03/20/26 | 182.62 on 03/20/26 | 344.95 on 03/20/26 | 136.49 on 03/20/26 | 56.91 on 03/20/26 |
| High | 1.3900 on 03/16/26 | 193.96 on 03/17/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | -10.69% since 02/20/26 | -10.09% since 02/20/26 | -7.19% since 02/20/26 | -9.37% since 02/20/26 | -5.24% since 02/20/26 |
| Low | 1.1600 on 03/20/26 | 182.62 on 03/20/26 | 344.95 on 03/20/26 | 136.49 on 03/20/26 | 56.91 on 03/20/26 |
| High | 1.4950 on 02/25/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -36.07% since 12/19/25 | +0.48% since 12/19/25 | +6.24% since 12/19/25 | +10.40% since 12/19/25 | +6.07% since 12/19/25 |
| Low | 1.1600 on 03/20/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.9000 on 12/22/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -38.42% since 09/19/25 | +20.35% since 09/19/25 | +21.86% since 09/19/25 | +20.26% since 09/19/25 | +27.68% since 09/19/25 |
| Low | 1.1600 on 03/20/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 2.3000 on 12/11/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,434 | 293,013,024 | 188,630,688 | 175,176,928 | 118,339,512 |
| Shares Outstanding, K | 26,585 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 10,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -42,080,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -24,460,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.77 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 10/30/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 16.09 | 17.34 | 9.65 |